These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6888088)

  • 21. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients.
    Schentag JJ; Cerra FB; Calleri GM; Leising ME; French MA; Bernhard H
    Clin Pharmacol Ther; 1981 Jun; 29(6):737-43. PubMed ID: 7226705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of cimetidine following administration of a single dose by the rapid intravenous route and by the oral route].
    Arancibia A; Schindler I; Paccot E; Ruiz I; Gonzalez G; Mella F; Thambo S
    Therapie; 1985; 40(2):87-92. PubMed ID: 4002195
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral absorption of cimetidine and its clearance in patients with renal failure.
    Larsson R; Bodemar G; Norlander B
    Eur J Clin Pharmacol; 1979 Apr; 15(3):153-7. PubMed ID: 456399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steady-state kinetics and dosage requirements of cimetidine in renal failure.
    Larsson R; Norlander B; Bodemar G; Walan A
    Clin Pharmacokinet; 1981; 6(4):316-25. PubMed ID: 7249490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cimetidine on the absorption and efficacy of orally administered furosemide.
    Rogers HJ; Morrison P; House FR; Bradbrook ID
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):8-11. PubMed ID: 7056605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective within-patient comparison clinical trial on the effect of parenteral cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome.
    Kato J; Sakamoto J; Teramukai S; Kojima H; Nakao A
    Hepatogastroenterology; 2004; 51(60):1742-6. PubMed ID: 15532817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood T lymphocytes in patients with duodenal ulcers treated with cimetidine.
    Gigi MR; Akriviadis E; Agorastos I; Goulis G
    Clin Exp Immunol; 1982 Apr; 48(1):186-8. PubMed ID: 6979447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine bioavailability after massive small bowel resection.
    Russo J; Watson WA; Nelson EW; Schentag JJ
    Clin Pharm; 1982; 1(6):558-61. PubMed ID: 7185547
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of phenobarbital treatment on cimetidine kinetics.
    Somogyi A; Thielscher S; Gugler R
    Eur J Clin Pharmacol; 1981; 19(5):343-7. PubMed ID: 7238562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic encephalopathy and altered cimetidine kinetics.
    Ziemniak JA; Bernhard H; Schentag JJ
    Clin Pharmacol Ther; 1983 Sep; 34(3):375-82. PubMed ID: 6883913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction of cimetidine with quinidine, procainamide and digoxin].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1437-9. PubMed ID: 3831993
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cimetidine disposition in patients with Laennec's cirrhosis during multiple dosing therapy.
    Cello JP; Oie S
    Eur J Clin Pharmacol; 1983; 25(2):223-9. PubMed ID: 6628505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cimetidine kinetics and dynamics in patients with severe liver disease.
    Villeneuve JP; Fortunet-Fouin H; Arsène D
    Hepatology; 1983; 3(6):923-7. PubMed ID: 6629322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cimetidine pharmacokinetics.
    Abate MA; Hyneck ML; Cohen IA; Berardi RR
    Clin Pharm; 1982; 1(3):225-33. PubMed ID: 6764387
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination.
    Patwardhan RV; Johnson RF; Sinclair AP; Schenker S; Speeg KV
    Gastroenterology; 1981 Sep; 81(3):547-51. PubMed ID: 7250643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.